Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Targets and their Inhibitors in Cancer Therapy
Le Zhao, Yongtao Duan, Ping Lü, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 18, Iss. 28, pp. 2395-2419
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
Atonu Chakrabortty, Daniel J. Patton, B. F. Smith, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1375-1375
Open Access | Times Cited: 113
Tazemetostat: EZH2 Inhibitor
Rachael Straining, William Eighmy
Journal of the Advanced Practitioner in Oncology (2022) Vol. 13, Iss. 2, pp. 158-163
Open Access | Times Cited: 102
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 132
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets
Antonino Lauria, Gabriele La Monica, Alessia Bono, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113555-113555
Closed Access | Times Cited: 67
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
Atonu Chakrabortty, Daniel J. Patton, B. F. Smith, et al.
(2023)
Open Access | Times Cited: 32
Is an “Epigenetic Diet” for Migraines Justified? The Case of Folate and DNA Methylation
Michał Fila, Cezary Chojnacki, Jan Chojnacki, et al.
Nutrients (2019) Vol. 11, Iss. 11, pp. 2763-2763
Open Access | Times Cited: 44
Differential molecular mechanistic behavior of HDACs in cancer progression
Tashvinder Singh, Prabhsimran Kaur, Paramdeep Singh, et al.
Medical Oncology (2022) Vol. 39, Iss. 11
Closed Access | Times Cited: 26
TSPAN8 promotes colorectal cancer cell growth and migration in LSD1-dependent manner
Hongsheng Zhang, Huiyun Liu, Zhen Zhou, et al.
Life Sciences (2019) Vol. 241, pp. 117114-117114
Closed Access | Times Cited: 38
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Víctor G. Martínez, Ester Munera-Maravilla, Alejandra Bernardini, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 36
Post-translational Acetylation Control of Cardiac Energy Metabolism
Ezra B. Ketema, Gary D. Lopaschuk
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 25
Crucial Role of Lysine-Specific Histone Demethylase 1 in RANKL-Mediated Osteoclast Differentiation
Mina Ding, Zhihao Chen, Eunjin Cho, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3605-3605
Open Access | Times Cited: 10
Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies
Azar Tahghighi, Effat Seyedhashemi, Javad Mohammadi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Chemical Tools with Fluorescence Switches for Verifying Epigenetic Modifications
Yuichiro Hori, Kazuya Kikuchi
Accounts of Chemical Research (2019) Vol. 52, Iss. 10, pp. 2849-2857
Closed Access | Times Cited: 27
Radiation-induced H3K9 methylation on E-cadherin promoter mediated by ROS/Snail axis : Role of G9a signaling during lung epithelial-mesenchymal transition
SunilGowda Sunnaghatta Nagaraja, Umadevi Subramanian, Devipriya Nagarajan
Toxicology in Vitro (2020) Vol. 70, pp. 105037-105037
Closed Access | Times Cited: 25
A New Twist in Protein Kinase B/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance
Isabell Götting, Verena Jendrossek, Johann Matschke
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8563-8563
Open Access | Times Cited: 24
(S)-2-(Cyclobutylamino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)isonicotinamide Attenuates RANKL-Induced Osteoclast Differentiation by Inhibiting NF-κB Nuclear Translocation
Mina Ding, Eunjin Cho, Zhihao Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4327-4327
Open Access | Times Cited: 9
The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker
Feifei Yang, Na Zhao, Yunjie Hu, et al.
Chemistry & Biodiversity (2019) Vol. 17, Iss. 1
Closed Access | Times Cited: 23
Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications
Yijia Li, Yangzhe Wu, Yi Hu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
Epigenetic tumor heterogeneity in the era of single-cell profiling with nanopore sequencing
Yohannis Wondwosen Ahmed, Berhan Ababaw Alemu, Sisay Addisu Bekele, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 14
The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer
Fernanda Wisnieski, Leonardo Caires Santos, Danielle Queiroz Calcagno, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 5, pp. 707-717
Closed Access | Times Cited: 19
Ultra performance liquid chromatography–tandem mass spectrometry assay for the quantification of RNA and DNA methylation
Jishuo Chang, Zhongxiao Lin, Yajuan Liu, et al.
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 197, pp. 113969-113969
Closed Access | Times Cited: 18
Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression
Dong Wang, Yan Zhang, Qingbo Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101020-101020
Open Access | Times Cited: 7
Jmjd2c maintains the ALDH bri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma
Min Wang, Yuling Hu, Feng Cai, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Identification of methylation‐driven genes related to prognosis in clear‐cell renal cell carcinoma
Jia Wang, Qiujing Zhang, Qingqing Zhu, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 2, pp. 1296-1308
Open Access | Times Cited: 17
Decreased H3K27me3 Expression Is Associated With Merkel Cell Polyomavirus-negative Merkel Cell Carcinoma, Especially Combined With Cutaneous Squamous Cell Carcinoma
Michiko Matsushita, Takeshi Iwasaki, Lusi Oka Wardhani, et al.
Anticancer Research (2019) Vol. 39, Iss. 10, pp. 5573-5579
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top